Skip to content

Drug interactions

Bortezomib + Bosentan

Severity: Moderate

Bortezomib and Bosentan: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Bosentan is a moderate CYP3A4 inducer and bortezomib is partly metabolized by CYP3A4, so bortezomib exposure may be reduced. The clinical significance is uncertain but reduced efficacy is possible.

What this interaction means in plain words

Bortezomib and Bosentan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Bortezomib belongs to Oncology; Bosentan belongs to Miscellaneous.

Evidence level: Low

Why it happens

Bosentan induces CYP3A4, increasing bortezomib metabolism.

What to do

Monitor disease response and consider an alternative to bosentan if loss of bortezomib efficacy is suspected.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bortezomib and Bosentan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Bortezomib with Bosentan?

MediHelp rates the interaction as moderate. Bortezomib and Bosentan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Bosentan is a moderate CYP3A4 inducer and bortezomib is partly metabolized by CYP3A4, so bortezomib exposure may be reduced. The clinical significance is uncertain but reduced efficacy is possible.

How serious is the interaction between Bortezomib and Bosentan?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor disease response and consider an alternative to bosentan if loss of bortezomib efficacy is suspected.

What other medicines interact with Bortezomib?

MediHelp also lists interactions of Bortezomib with, for example, Apalutamide, Carbamazepine, Etrasimod. The full list is on the Bortezomib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in